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Abstract
Background: Bloodstream infections (BSI) have been traditionally classified as either community acquired (CA) or
hospital acquired (HA) in origin. However, a third category of healthcare-associated (HCA) community onset disease
has been increasingly recognized. The objective of this study was to compare and contrast characteristics of HCA-
BSI with CA-BSI and HA-BSI.
Methods: All first episodes of BSI occurring among adults admitted to hospitals in a large health region in Canada
during 2000-2007 were identified from regional databases. Cases were classified using a series of validated
algorithms into one of HA-BSI, HCA-BSI, or CA-BSI and compared on a number of epidemiologic, microbiologic,
and outcome characteristics.
Results: A total of 7,712 patients were included; 2,132 (28%) had HA-BSI, 2,492 (32%) HCA-BSI, and 3,088 (40%) had
CA-BSI. Patients with CA-BSI were significantly younger and less likely to have co-morbid medical illnesses than
patients with HCA-BSI or HA-BSI (p < 0.001). The proportion of cases in males was higher for HA-BSI (60%; p <
0.001 vs. others) as compared to HCA-BSI or CA-BSI (52% and 54%; p = 0.13). The proportion of cases that had a
poly-microbial etiology was significantly lower for CA-BSI (5.5%; p < 0.001) compared to both HA and HCA (8.6 vs.
8.3%). The median length of stay following BSI diagnosis 15 days for HA, 9 days for HCA, and 8 days for CA (p <
0.001). Overall the most common species causing bloodstream infection were Escherichia coli, Staphylococcus
aureus, and Streptococcus pneumoniae. The distribution and relative rank of importance of these species varied
according to classification of acquisition. Twenty eight day all cause case-fatality rates were 26%, 19%, and 10% for
HA-BSI, HCA-BSI, and CA-BSI, respectively (p < 0.001).
Conclusion: Healthcare-associated community onset infections are distinctly different from CA and HA infections
based on a number of epidemiologic, microbiologic, and outcome characteristics. This study adds further support
for the classification of community onset BSI into separate CA and HCA categories.
Background
Bloodstream infections (BSI) are an important cause of
morbidity and mortality. Traditionally these have been
classified into either community acquired (CA) or hospi-
tal acquired (HA) infections for epidemiological and
infection prevention and control purposes [1]. Nosoco-
mial or hospital acquired infections are commonly
defined as those that have onset after admission or are
associated with acquisition in the hospital environment,
whereas community-acquired infections have been
defined as those present or incubating at the time of
hospital admission [1]. However, in recent years, there
has been a shift in the delivery of healthcare services
such that increasingly complex medical services are
being provided in the community environment [2]. As a
result, community based patients may now present to
hospital with infections that share many characteristics
with HA infections [3,4].
In 2002, Freidman et al. proposed the sub-classifica-
tion of community onset BSI (obtained as outpatients or
identified within 48 hours of hospital admission) into
CA and healthcare associated (HCA) BSI [5]. The HCA
infections were identified with recent hospital admission
or exposure to significant medical care in a community
or outpatient setting, while CA infections described
other community onset BSI that did not have significant
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among a study cohort of 504 patients, as compared to
CA-BSI, HCA-BSI had significantly more associated co-
morbid disease, increased risk for antimicrobial resis-
tance, and higher mortality. Since then, a limited num-
ber of other studies have been conducted that further
support the value of this new classification category
[6-10]. However, several studies conducted to date have
been limited by either relatively small sample size and
therefore power to detect important differences in cate-
gories or have been conducted in selected populations
or university based hospitals which may limit broad gen-
eralization of results. The objective of this study was to
assess the epidemiology and outcome of BSI infections
by acquisition classification among all adults admitted
to hospitals in a large Canadian population.
Methods
Patient population
This study utilized an inception cohort design. The Cal-
gary Zone of Alberta Health Services (formerly known as
the Calgary Health Region) is a fully integrated, publicly
funded health system that provides virtually all medical
and surgical care to the residents of the cities of Calgary
and Airdrie and a large surrounding area including a num-
ber of smaller towns and communities (population ~ 1.2
million). All Calgary Zone adult (≥ 18 years) residents
admitted to one of the three adult major acute care cen-
tres in the region (representing > 95% of all acute care
admissions) with first episodes of BSI during January 1
st,
2000 and December 31
st, 2007 were included in this study.
This study was approved by the Conjoint Health Research
Ethics Board at the University of Calgary.
Study protocol
All study subjects were identified using the Electronic Sur-
veillance System (ESS) Database [11]. The ESS Database
was developed by a multidisciplinary group of microbiolo-
gists, infectious disease specialists, and information tech-
nology and quality and safety experts and has registered
all residents of the Calgary Zone with BSI since 2000. This
database has been developed through linkages between
regional microbiology and acute care hospital administra-
tive databases with validated algorithms used to define
incident episodes of BSI and allow their classification as
either CA, HCA, or HA. Although patients managed in
the community are included in the ESS, detailed clinical
data is only available for those admitted to hospital. Only
patients admitted to hospital were included in this study.
Definitions
A BSI in the ESS database is defined as the isolation of a
pathogen from ≥ 1 set of blood cultures, or ≥ 2s e t so f
blood cultures drawn within 5 days for organisms
commonly associated with contamination including
diptheroids, Bacillus spp., Propionibacterium spp, coagu-
lase negative-staphylococci, viridans group streptococci,
and micrococci [12]. Patients with more than one species
isolated from blood within 48 hours were considered to
have polymicrobial BSI. Hospital acquired BSI was
defined as a first positive blood culture ≥ 48 hours after
hospital admission or within 48 hours of discharge from
hospital. If transferred from another regional acute care
institution then the duration of admission was calculated
from admission time at the first hospital. A HCA-BSI
was defined as first culture obtained < 48 hours of admis-
s i o na n da tl e a s to n eo f :1 )v i s i tt oah o s p i t a lc l i n i co r
emergency department within the prior 5-30 days before
o n s e to fB S I ;2 )h o s p i t a l i z a t i o na taC a l g a r yZ o n ea c u t e
care hospital for 2 or more days within the prior 90 days
before BSI; 3) sample submitted for culture from a nur-
sing home or long term care facility; 4) receipt of dialysis;
or 5) active cancer. Community-acquired infections are
those with first positive culture obtained < 48 hours of
admission and not fulfilling criteria for healthcare asso-
ciated classification. The Charlson score, a weighted
index of 17 co-existing medical conditions, was used as
the measure of co-morbid illness and was derived from
discharge codes using algorithms previously developed
and validated in Calgary [13,14].
Data management and statistical analysis
Analysis was performed using Stata version 11.2 (Stata
Corp, College Station, TX). To avoid the assessment of
multiple outcomes for a single patient, only the first
admission per patient was included in this study. Non-
normally distributed variables were reported as medians
with inter-quartile ranges (IQR) and compared using the
Mann-Whitney U test. Differences in proportions among
categorical data were assessed using Fisher’s exact test for
pair-wise comparisons and the chi squared test for multi-
ple groups. P-values less than 0.05 were considered to be
significant.
Results
Patients and acquisition classification
During the eight year study period, 7,712 adult residents
had first admissions associated with an incident BSI. Of
the studied inpatient population, 2,132 (28%) were HA-
BSI, 2,492 (32%) HCA-BSI, and 3,088 (40%) were CA-BSI.
Among patients with HA-BSI, the median time to positive
blood culture after admission was 10.4 (IQR, 4.8-20.2)
days. Among the group of patients classified as HCA-BSI
(n = 2,492), 1,164 (47%) had been admitted to an acute
care hospital for two or more days within the prior 90
days before BSI, 714 (29%) attended a hospital clinic or
emergency department within the prior 5-30 days before
BSI, 584 (23%) were cancer patients, 395 (16%) were
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170 (7%) were hemodialysis patients. A number of demo-
graphics and clinical characteristics were different in each
category of acquisition classification as shown in Table 1.
Microbiology
Overall the most common species causing bloodstream
infection was Escherichia coli, Staphylococcus aureus,
and Streptococcus pneumoniae. The distribution and
relative rank of prevalence of these species varied
according to classification of acquisition as shown in
Table 2. Among Escherichia coli isolates, rates of cipro-
floxacin resistance were significantly (p < 0.001) higher
among HA-BSI (52/318; 16%) and HCA-BSI (104/649;
16%) as compared to CA-BSI (83/959; 9%) and this was
also observed for resistance to ceftriaxone (HA 22/316;
7% vs. HCA 34/646; 5% vs. CA 22/953; 2%; p < 0.001).
The proportion of methicillin-resistant Staphylococcus
aureus (MRSA) isolates was similar between HA-BSI
and HCA-BSI (97/607; 16% vs. 75/475; 16%; p = 1.0),
while this was significantly lower in CA-BSI (27/366;
7%; p < 0.001). The overall rate of penicillin resistance
in S. pneumoniae was low (41/658; 6%) and was not dif-
ferent among the acquisition categories (p = 0.83).
Outcomes
The overall median length of hospital stay was 11 days
(IQR, 6 to 27 days). There was a significant (p < 0.001)
difference in the median length of stay following BSI
diagnosis among HA-BSI patients (15 days, IQR, 6 to 36)
as compared to HCA (9 days, IQR, 5 to 18) and CA-BSI
(8 days, IQR 4 to 14). The overall all-cause inpatient
case-fatality rate was 1,423/7,712 (18%). Significantly
more in-hospital deaths were seen in patients with HA-
BSI (639/2,132; 30%) than in patients with HCA-BSI
(449/2,492; 18%; p < 0.001) which in turn had a higher
mortality rate than CA-BSI (335/3,088; 11%; p < 0.001).
Similarly, 28-day all cause mortality was highest in HA-
BSI (554/2,132; 26%), compared to HCA-BSI (460/2,492;
18%) and CA-BSI (307/3,088; 10%). Differences were sig-
nificant (p < 0.001) between each category.
Discussion
In this study we found that significant differences
between the three acquisition classifications in relation
to demographics, co-morbidities, microbiology, and hos-
pital course and mortality outcomes. On one hand, the
characteristics of HCA-BSI were similar to HA-BSI as
regards age, the proportion of MRSA, and poly-micro-
bial infections. On the other hand, HCA-BSI resembled
CA-BSI in length of stay and the proportion of males.
However, features of HCA-BSI were intermediate
between HA and CA-BSI as regards infecting species,
distribution of co-morbidities, and mortality (Tables 1
and 2). Overall, we consider HCA-BSI to represent a
category that is intermediate in clinical, microbiological,
and outcome characteristics between HA-BSI and CA-
BSI among patients requiring admission to hospital.
This study confirms HCA-BSI as a distinct acquisition
category and further supports its use in surveillance and
in epidemiology studies of infection.
We modeled our study definitions based on those pro-
posed by Freidman et al [5] and found generally similar
findings with their landmark study. Among their cohort
of 504 patients with BSI, they found that E. coli and S.
pneumoniae were most common in CA, and that S. aur-
eus was the most common in HA and HCA disease. They
reported that MRSA occurred with similar frequency
among HCA and HA but much lower in CA-BSI. Our
results are consistent with these findings with the notable
exception that E. coli was found to be the most common
cause of HCA-BSI in our study (Table 2). In addition,
Table 1 Characteristics of admitted adults with incident episodes of bloodstream infection according to acquisition
classification, Calgary, 2000-2007
Hospital Acquired
(HA-BSI)
Healthcare-Associated
(HCA-BSI)
Community-Acquired
(CA-BSI)
HA vs
HCA P
HA vs
CA P
HCA vs
CA p
Age (IQR) years 68.0 (53.1-78.0) 70.8 (54.9-81.0) 61.2 (45.7-75.0) < 0.001 < 0.001 < 0.001
Male (%) 1,282 (60%) 1,284 (52%) 1,654 (54%) < 0.001 < 0.001 0.131
Poly-microbial 183 (9%) 206 (8%) 170 (6%) 0.710 < 0.001 < 0.001
Median Charlson (IQR) score 2 (1-4) 2 (0-4) 1 (0-2) < 0.001 < 0.001 < 0.001
Charlson category < 0.001 < 0.001 < 0.001
0 422 (20%) 633 (25%) 1,525 (49%)
1 327 (15%) 433 (17%) 687 (22%)
2 453 (21%) 535 (21%) 355 (12%)
≥ 3 928 (44%) 890 (36%) 520 (17%)
In-hospital all-cause crude
mortality
639/2,132 (30%) 449/2,492 (18%) 335/3,088 (11%) < 0.001 < 0.001 < 0.001
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was similar among HA- and HCA-BSI and higher than in
CA-BSI, and that hospital length of stay was much longer
in HA-BSI but similar in HCA- and CA-BSI. Further-
more, they observed that in-hospital mortality rates were
higher in HA-BSI (30%), as compared to HCA-BSI (20%),
and CA-BSI (13%). Although clinically significant, they
did not find statistically significant difference between
HCA-BSI and CA-BSI in-hospital mortality that was
likely related to limited statistical power. While our study
mirrors these differences in mortality rates between the
acquisition categories, our more than 10-fold larger sam-
ple size had adequate power to detect statistically signifi-
cant differences in mortality outcome between each
acquisition category both with respect to in-hospital
death as well as 28-day mortality.
A number of other studies have investigated alternate
definitions for community onset BSI or have evaluated
HCA-BSI in different populations of patients [3]. Sieg-
man-Igra proposed four main different categories (with
five other subgroups) for community onset BSI and found
a number of different demographic, clinical, and outcome
differences among 569 patients admitted to a large univer-
sity hospital in Tel Aviv in 1997 [3].
Son et al investigated more than 1,144 BSI isolates
obtained from 9 university hospitals in Korea [6]. As in
our study, they found that E. coli was the most common
pathogen in HCA- and CA-BSI and S. aureus in HA-BSI,
that co-morbidities were most prevalent in HA- and
HCA-BSI, and that there was a decreasing risk for 30-day
mortality from HA- (23%), to HCA- (18%) to CA-BSI
(10%). Valles et al investigated 1,157 episodes of BSI
among adults admitted to three Spanish teaching hospi-
tals and found that as compared to patients with CA-BSI,
patients with HCA-BSI were more likely to have MRSA
infection and suffered significantly higher mortality [7].
McDonald and colleagues investigated 466 BSI at three
North Carolina hospitals and found that as compared to
CA-BSI, HCA-BSI was an independent predictor of
inadequacy of treatment and this was most strongly
related to prior hospitalization within the prior 90 days
[8]. Shorr et al investigated a cohort of 6,697 patients
admitted to 59 hospitals in the United States and found
that HCA-BSI had more co-morbid illness and a higher
proportion of MRSA as compared to CA-BSI [9]. In addi-
tion, they found that the length of stay was similar
between HCA-BSI and CA-BSI but less than for HA-BSI,
and that the mortality rates for CA-BSI of 10% was sig-
nificantly less than for HCA-BSI (15%) and HA-BSI
(15%). It is notable that they did not find a difference in
mortality among HA-BSI and HCA-BSI and this may be
explained in part by their focus on inclusion of patients
with cultures obtained in the first five days after admis-
sion to hospital. Kollef and colleagues compared HCA-
BSI and CA-BSI among 1,143 patients admitted to 7
American hospitals and found that patients with HCA-
BSI were older, were more likely to be male, presented
with higher severity of illness, had longer lengths of stay,
a n dw e r em o r el i k e l yt od i e[ 1 0 ] .T h e yd i dn o te x a m i n e
HA-BSI. A number of other studies have investigated the
category of HCA-BSI but these have been limited to
restricted populations or infecting etiologies [15-18].
D e s p i t et h eg r o w i n gb o d yo fe v i d e n c es u p p o r t i n gt h e
unique nature of HCA-BSI, there is still failure to univer-
sally recognize this classification in contemporary BSI defi-
nitions and literature, including the current Centers for
Disease Control definition for healthcare associated (pre-
viously nosocomial) infections [19]. Using these definitions,
BSI detected after 48 hours of hospitalization is designated
HA, with the remainder of all episodes classified CA-BSI by
default, including those that would fall into the proposed
HCA-BSI category. An exception is the MRSA classifica-
tion, which includes a distinct healthcare associated - com-
munity onset category analogous to HCA-BSI [20].
Identification of the HCA-BSI category has a number of
implications for surveillance. Hospital-acquired infections
Table 2 Ten most common isolates causing bloodstream infection by acquisition classification, Calgary, 2000-2007
Species Overall (%) HA (%) HCA (%) CA (%)
Escherichia coli 2,052 (24) 340 (14) 689 (25) 1,023 (31)
Staphylococcus aureus 1,448 (17) 607 (26) 475 (17) 366 (11)
Streptococcus pneumoniae 686 (8) 39 (2) 177 (6) 470 (14)
Coagulase negative staphylococcus 497 (6) 241 (10) 160 (6) 96 (3)
Klebsiella pneumoniae 482 (6) 135 (6) 184 (7) 163 (5)
Enterococcus faecalis 286 (3) 115 (5) 103 (4) 68 (2)
Bacteroides fragilis 262 (3) 86 (4) 79 (3) 97 (3)
Group A streptococcus 244 (3) 18 (4) 75 (3) 151 (5)
Pseudomonas aeruginosa 220 (3) 105 (4) 83 (3) 32 (1)
Group B streptococcus 168 (2) 27 (1) 53 (2) 88 (3)
Other 2,039 (24) 637 (27) 671 (24) 731 (22)
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towards increasing delivery of complex care in the com-
munity setting, decreasing numbers of cases of HA-BSI
may be falsely viewed as a marker of success if HCA-BSI’s
are not tracked to ensure that there is not a concomitant
increase in these infections. Similarly, identification of
emerging resistant organisms in the community may be
falsely attributed to some community based factor (such
as travel, food exposures, environmental contamination) if
a healthcare associated linkage is not recognized [21]. Per-
haps most importantly, failure to recognize that HCA-BSI
have higher rates of resistance than CA-BSI may lead to
adverse outcomes as a result of increased risk for treat-
ment failure [6,8].
While our study benefits from large sample size and
comprehensive inclusion of all cases occurring in a large
well-defined population there are some limitations that
are noteworthy. We obtained all of our patient informa-
tion from our Electronic Surveillance System that is
based solely on source data available from regional and
provincial databases [11]. We did not have data on spe-
cialized home care, immuno-suppressive medication use,
and ambulatory parenteral antibiotherapy. As a result, we
had to make minor modifications of the definitions of
Friedman et al [5] and did not perform a case-by-case
individual chart or patient review in this study. Thus, it is
possible that our assignment of patients to acquisition
categories may not have been as precise as if we had per-
formed a case-by-case individual review and subsequently
patients may have been misclassified. However, our clas-
sification of acquisition by the ESS has been previously
demonstrated to be highly accurate based on a retrospec-
tive comparative review of 306 patients in development
[11], and a further 300 plus cases in validation (manu-
script in preparation). It is important to note that while
o u rr e s u l t sa r ec o m p a r a b l et ot h es t u d yb yF r i e d m a n
because of the similar definitions used [5], generalization
a n dc o m p a r i s o nw i t ho t h e rs t u d i e st h a tu s e dd i f f e r e n t
definitions should be done cautiously [3,6-10]. Another
limitation of our study is that we did not have informa-
tion on treatments prescribed as it would be interesting
to evaluate whether the HCA-BSI category were at
increased risk for inadequate empiric antibiotic therapy.
While we report selected resistance rates in this study,
we do not present overall group specific resistance rates
and therefore may not be recognizing further important
differences in acquisition categories. A third limitation is
that we did not assess sources of infection, and their may
be significant differences in the distribution of foci of
infections among the different acquisition classifications.
Finally, like all of the other studies conducted to date, we
only included patients admitted to hospital. The possibi-
lity does exist that HCA-BSI and CA-BSI differ further in
this non-admitted population.
Conclusions
In this study we found that HCA-BSI were a distinct
category of BSI that have features intermediate between
CA-BSI and HCA-BSI. These data add further support
for the classification of community onset BSI into CA-
BSI and HCA-BSI in infectious diseases surveillance and
inclusion in guidelines guiding empiric antimicrobial
therapies in patients presenting to hospital with infec-
tious diseases.
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